? ? ?
The Woodlands, TX, October 02, 2012 ?(PR.com)? Judge Rogers concludes that the ?340 patent, which was asserted by Kaneka in a complaint filed with the ITC in June 2011, is valid but is not infringed by ZMC?s manufacturing process.
Johnny Jin, President & CEO of ZMC-USA, indicated that he is pleased with this favorable ruling. "ZMC and ZMC-USA have consistently maintained our position of non-infringement since the Kaneka patent first issued. We are thankful to our customers who have continued to support ZMC-USA and we look forward to resuming service of those customers who have been negatively impacted by this unnecessary litigation." Mr. Jiang, CEO of ZMC, echoed Mr. Jin's comments. "ZMC is proud to have demonstrated the integrity of ZMC?s CoQ10 process to Judge Rogers of the U.S. ITC and all the dedicated staff who reviewed this important case. We look forward to resuming productive efforts which positively serve our valued customers."
About: Zhejiang Medicine Co Ltd (ZMC) is a multicultural raw ingredient manufacturer offering high quality leading edge pharmaceutical and nutraceutical ingredients worldwide since 1954. ZMC is staffed with over 5,000 employees worldwide and is an important production base of microbiological drugs, Coenzyme Q10, Biotin, Vitamins A and E, Lutein, Phytosterol, B-Carotene, and Lycopene.
Contact Information:
ZMC ? USA
Johnny Jin
+1.281.419.6050
Contact via Email
www.zmc-usa.com
Click here to read the full story: ITC Judge Rules in Favor of ZMC and ZMC-USA Over Kaneka in CoQ10 Litigation
Press Release Distributed by PR.com
julia gillard pecan pie the hobbit trailer red velvet cake recipe josh krajcik porphyria cinnamon rolls
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন